Abstract
Liver diseases, including viral hepatitis, resulting from hepatitis B or C virus infection, liver cirrhosis and hepatocellular carcinoma pose great global health challenges due to the limited curative treatment options. The application of nanoparticles has emerged as a rapidly evolving area for safely delivering therapeutic agents (i.e. drugs and nucleic acid) to treat a range of diseases, including those of the liver. In this chapter, we give an overview of various nanotechnology approaches which can be employed when treating liver diseases, focusing in particular on liver infections, fibrosis and cancer.
Keywords: Drug delivery, HBV, HCC, HCV, liver cirrhosis, liver diseases, liver fibrosis, nanoparticles.
Related Books
Frontiers in Nano and Micro-Device Design for Applied Nanophotonics, Biophotonics and Nanomedicine
Nanomaterials and Their Interactive Behavior with Biomolecules, Cells and Tissues
Nanotherapeutic Strategies and New Pharmaceuticals (Part 1)
Nanotherapeutic Strategies and New Pharmaceuticals (Part 2)
On-Chip Pretreatment of Whole Blood by Using MEMS Technology
Polymeric Nanomedicines
Toxic Effects of Nanomaterials
Frontiers in Biomaterials
Frontiers in Biomaterials
Frontiers in Biomaterials